Company profile: CeloNova BioSciences
1.1 - Company Overview
Company description
- Provider of interventional cardiology and endovascular products, including Polyzene-F nano-thin biomimetic coatings for implants to reduce thrombogenicity, inflammation and promote rapid healing; Xero-Gel drug-coated PTCA balloons for small vessel stenosis, restenosis and bifurcations; and COBRA PzF NanoCoated non-drug eluting coronary stents for patients with a short 1-month dual antiplatelet therapy requirement. Offers partnership and co-development opportunities.
Products and services
- COBRA PzF NanoCoated Coronary Stent (NCS): A non-drug eluting coronary stent with Polyzene-F nanocoating, engineered to treat patients needing only 1‑month dual antiplatelet therapy
- Polyzene-F NanoCoating: A nano-thin biomimetic coating for medical implants that reduces thrombogenicity and inflammation and promotes rapid healing
- Xero-Gel Drug-Coated PTCA Balloon: A bio-active coated PTCA balloon developed to improve drug delivery for treating small vessel stenosis, restenosis, and bifurcations
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to CeloNova BioSciences
EPD Solutions
HQ: Spain
Website
- Description: Provider of cardiac imaging and navigation systems, dedicated to improving the efficacy and efficiency of minimally invasive catheter-based procedures to treat cardiac arrhythmias; a Dutch company and member of the Hobart Group companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EPD Solutions company profile →
Millipede Medical
HQ: United States
Website
- Description: Provider of a percutaneous, catheter-based solution for mitral valve repair and treatment of mitral and tricuspid regurgitation, restoring health and expanding options for physicians and patients globally.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Millipede Medical company profile →
VerAvanti
HQ: United States
Website
- Description: Provider of single-use intravascular endoscopic technologies, including a Scanning Fiber Endoscope delivering real-time, high-resolution images of intravascular anatomy to help diagnose and treat stroke and cardiovascular events; in-house MEMS manufacturing of micro-small components using precise robotics and cleanroom assembly; and O-pH imaging to measure oral biofilm acidity to predict and manage tooth decay.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full VerAvanti company profile →
Verathon
HQ: United States
Website
- Description: Provider of medical devices and services, designing, manufacturing and distributing solutions for airway management and bladder volume measurement, including GlideScope video laryngoscopes, GlideScope Core airway visualization systems, GlideScope Go 2 for EMS, GlideScope Spectrum QC single-use laryngoscopes, BFlex single-use bronchoscopes, and BladderScan ultrasound devices with AI.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Verathon company profile →
Lombard Medical
HQ: United Kingdom
Website
- Description: Provider of minimally invasive endovascular stent graft systems for aortic aneurysm repair, developing, manufacturing and marketing solutions for EVAR and TEVAR. Products include Minos, Aorfix (for highly angulated aortic necks), Altura and Meridian (non-standard, named-patient) for EVAR, and Hercules and Castor (custom branched, named-patient) for thoracic cases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lombard Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for CeloNova BioSciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to CeloNova BioSciences
2.2 - Growth funds investing in similar companies to CeloNova BioSciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for CeloNova BioSciences
4.2 - Public trading comparable groups for CeloNova BioSciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →